Miracor Medical SA’s Post

The PACE Phase 3 results are published. This publication serves as a comprehensive resource for stakeholders invested in medical research, offering valuable insights into the study's progression. Congratulations to all contributors on this milestone achievement, marking a pivotal moment in advancing medical knowledge. #ClinicalOutcomes #CLI #CLTI #stemcells #PACEPhase3

For oncologists, most patients come from outside clinics and therefore, communication and seamless collaboration are key requirements. A patient's medical history is critical. Requesting information from other offices has proven to be a complex and time-consuming task that requires many back and forths, with sometimes very limited success. Read Vivlio's blog on what oncologists can do to address the challenge with acquiring medical records here: https://hubs.ly/Q02xsXx70

SAVE THE DATE! 3rd Annual Bradley Z. Naifeh Amyloidosis Conference - HOUSTON Amyloidosis is an underrecognized condition because it has historically been misconceived to be a rare disease and presents in a myriad of clinical situations in a subtle manner. Recent advances in therapeutics have made it imperative that this condition is recognized and categorized appropriately in a timely manner so that individuals can get access to appropriate care. Due to a systemic nature of amyloid, various subspecialities are on the fore front of battling this disease. The goal of the Conference is to create a faculty panel from various disciplines to engage in the mission to promote awareness and educate attendees on Amyloidosis in a comprehensive manner. SAVE THE DATE: 2025 Bradley Z. Naifeh Amyloidosis Conference: March 21, 2025 - provider day March 22, 2025 - patient day https://lnkd.in/edxmcZBj

For oncologists, most patients come from outside clinics and therefore, communication and seamless collaboration are key requirements. A patient's medical history is critical. Requesting information from other offices has proven to be a complex and time-consuming task that requires many back and forths, with sometimes very limited success. Read Vivlio's blog on what oncologists can do to address the challenge with acquiring medical records here: https://hubs.ly/Q02xsZVP0

Endovascular thrombectomy plus medical care versus medical care alone for large ischaemic stroke: 1-year outcomes of the SELECT2 trial Prof Amrou Sarraj, MD, Prof Michael G Abraham, MD https://lnkd.in/gJHWT2dq

"When we discuss trial participation with patients, we stress that the goal of these studies is to obtain better visual outcomes and ease the treatment burden." In her article, Pamela Ann Weber, MD shares insights into discussing clinical trials with patients and the value that participating in these trials can have for both patients and providers. Read the full article: https://lnkd.in/eT4cQYM8

Understanding bias in randomized trials - crucial knowledge for every physician A thorough comprehension of bias in randomized trials is indispensable for every physician, as it underpins the accurate interpretation of clinical research and the delivery of evidence-based care https://lnkd.in/d-cnYiqH

Could not be more proud to have contributed to this landmark study demonstrating the superiority of 3-level CCF over ACDF. @Providence Medical Technology, Inc. we are changing the standard of care for multilevel fusion patients. 🩻🧡 #clinicalstudy #data #ccf #acdf #news #medicaldevice #spine #spinesurgery

View new session of the ‘Best Practice Exchange in Clinical Case Scenarios’ to listen to experts in UC discussing the latest evidence supporting the optimal utilization of sequential treatments. https://lnkd.in/ecjStWAe

February is an American Heart Month. Throughout the next week, you can expect: ✅ daily LinkedIn posts dedicated to drugs and genes related to Cardiology ✅ Sneak peak to a newsletter dedicated to this PGx in Cardiology (PRICKLY PILL link in Featured) ✅ highlighting landmark studies and research that involves AI Speaking of landmark studies and the revie process, I highly recommend you check out the following resource: https://lnkd.in/g4bp8eep #pharmacogenomics #cardiology #precisionmedicine #aiinmedicine